It caps off the first full quarter with David Joyner, a longtime CVS executive, as CEO of the troubled retail drugstore chain.
Related Posts
China’s central bank keeps medium-term loan rate unchanged amid yuan weakness
The yuan has come under pressure following Donald Trump’s victory in the U.S. presidential election.
Tech stocks are among those that are still cheap and loved by Wall Street heading into 2025
DocuSign and IBM-spinoff Kyndryl are among the stocks that are trading at attractive valuations amid the recent run-up in tech names.
The auto industry is pulling back on its ‘capital junkie’ tendencies after unprecedented spending on EVs, self-driving
After years of spending capital freely on all-electric and autonomous vehicles, automakers are starting to pull back.